Tek/Tie2 signaling: New and old partners

Cancer and Metastasis Reviews

Volumn 19, Issue 1-2, 2000, Pages 13-17

  Jones, Nina ^a   Dumont, Daniel J ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Angiogenesis; Angiopoietin; Signal transduction; Tek Tie2

Indexed keywords

ANGIOPOIETIN; LIGAND; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; CELL SURVIVAL; ENDOTHELIUM CELL; GROWTH INHIBITION; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

ANIMALS; HUMANS; MODELS, CARDIOVASCULAR; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-2; SIGNAL TRANSDUCTION;

EID: 0034534821     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026555121511     Document Type: Review

References (40)

1. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
2. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
3. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans
4. Characterization of a novel form of angiopoietin-2 (Ang-2B) and expression of VEGF and angiopoietin-2 during chicken testicular development and regression
5. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
6. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
7. Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis
8. Mechanisms and consequences of activation of protein kinase B/Akt
9. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt
10. Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration
11. Angiopoietin-1 is an apoptosis survival factor for endothelial cells
12. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway
13. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells
14. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells
15. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
16. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway
17. Tie 2 expression and phosphorylation in angiogenic and quiescent adult tissues
18. Expression of angiopoietin-1, angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation
19. Embryonic angiogenesis: A review
20. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2
21. Angiopoietin-1 induces sprouting angiogenesis in vitro
22. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
23. Angiopoietin- 1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion
24. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R
25. GRB2 and SH-PTP2: Potentially important endothelial signaling molecules downstream of the TEK/TIE 2 receptor tyrosine kinase
26. Association of focal adhesion kinase with Grb 7 and its role in cell migration
27. Proteintyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion
28. Protein modules and signalling networks
29. Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation
30. FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation
31. Identification of the rat adapter Grb 14 as an inhibitor of insulin actions
32. Association of fibroblast growth factor receptor 1 with the adaptor protein Grb14. Characterization of a new receptor binding partner
33. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2
34. HCPTPA, A protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity
35. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase Tie2
36. Allelic and locus heterogeneity in inherited venous malformations
37. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: Mutant Tie-2 causing venous malformations signals a distinct STAT activation response
38. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth
39. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
40. Two independent mechanisms essential for tumor angiogenesis: Inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway